Filter Results:
(3,127)
Show Results For
- All HBS Web
(3,127)
- People (9)
- News (512)
- Research (2,164)
- Events (8)
- Multimedia (22)
- Faculty Publications (1,752)
Show Results For
- All HBS Web
(3,127)
- People (9)
- News (512)
- Research (2,164)
- Events (8)
- Multimedia (22)
- Faculty Publications (1,752)
- February 2003 (Revised July 2003)
- Case
Ember Corporation: Developing the Next Ubiquitous Network Standard
By: Rebecca Henderson and Nancy Confrey
Ember is a venture capital-funded start-up that hopes to establish a standard for ubiquitous wireless networks. Its unique approach and proprietary technology promises to create enormous value in a wide variety of markets, particularly in local sensing and control.... View Details
Keywords: Business Startups; Wireless Technology; Value; Competitive Strategy; Standards; Technology Industry; Technology Industry
Henderson, Rebecca, and Nancy Confrey. "Ember Corporation: Developing the Next Ubiquitous Network Standard." Harvard Business School Case 703-448, February 2003. (Revised July 2003.)
- February 2015 (Revised November 2015)
- Supplement
Building an Integrated Biopharma Company: Crucell (B)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan Harmeling
The Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing Agreements In Biopharmacy; Licensing; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Entrepreneurship; Health Care and Treatment; Acquisition; Innovation and Invention; Biotechnology Industry; Pharmaceutical Industry
Hamermesh, Richard G., Marianne Van Der Steen, and Susan Harmeling. "Building an Integrated Biopharma Company: Crucell (B)." Harvard Business School Supplement 815-086, February 2015. (Revised November 2015.)
- 10 Jul 2015
- Blog Post
Can Entrepreneurship Be Taught?
challenges for founders. At HBS, Professor Bussgang has taught the Launching Technology Ventures course. ----------------- I came to HBS six years ago at a time when the school was ramping up its... View Details
- 26 Mar 2020
- Blog Post
The Road Untraveled: VC Perspectives on COVID-19
Brian Hollins (MBA 2021) spent six years at Goldman Sachs prior to HBS focused on venture capital and growth equity investing for the firm. He will be joining Lightspeed Venture Partners this summer, and is... View Details
- September 2005 (Revised May 2007)
- Case
OuterLink Corporation (A)
By: Josh Lerner and Brenda Chia
Zero Stage Capital is addressing a troubled investment in OuterLink Corp., which has a capital deficit of $30 million and was written off by all but one of its investors as a victim of the technology bubble. The venture organization must decide whether to shutter the... View Details
Keywords: Information Technology; Decisions; Venture Capital; Private Equity; Price Bubble; Investment; Financial Services Industry
Lerner, Josh, and Brenda Chia. "OuterLink Corporation (A)." Harvard Business School Case 806-059, September 2005. (Revised May 2007.)
- 2024
- Working Paper
Appropriate Entrepreneurship? The Rise of China and the Developing World
By: Josh Lerner, Junxi Liu, Jacob Moscona and David Yang
Global innovation and entrepreneurship has traditionally been dominated by a handful
of high-income countries, especially the US. This paper investigates the international
consequences of the rise of a new hub for innovation, focusing on the dramatic
growth of... View Details
Lerner, Josh, Junxi Liu, Jacob Moscona, and David Yang. "Appropriate Entrepreneurship? The Rise of China and the Developing World." Harvard Business School Working Paper, No. 24-061, March 2024.
- June 2012
- Case
Innovating at AT&T: Partnering to Lead the Broadband Revolution
By: Lynda M. Applegate, Phillip Andrews and Kerry Herman
In 2010, the U.S. retail market value for next-generation non-handset wirelessly-enabled devices was just over $1 billion. By 2011 it had grown 1,141% to $13.2 billion and was forecast to reach $24.7 billion in 2015. At the same time, user demand for data was surging... View Details
Keywords: Innovation ＆ Entrepreneurship; Team Leadership; Emerging Technologies; Business Models; Business To Business; Corporate Vision; Growth Strategy; Corporate Culture; Innovation and Invention; Corporate Entrepreneurship; Partners and Partnerships; Leadership; Mobile and Wireless Technology; Growth and Development Strategy; Globalized Firms and Management; Business Model; Technology Industry; United States
Applegate, Lynda M., Phillip Andrews, and Kerry Herman. "Innovating at AT&T: Partnering to Lead the Broadband Revolution." Harvard Business School Case 812-124, June 2012.
- September–October 2020
- Article
The Past, Present, and (Near) Future of Gene Therapy and Gene Editing
By: Julia Pian, Amitabh Chandra and Ariel Dora Stern
Emerging gene therapy and gene-editing technologies will have a growing impact on patient lives and health-care delivery. We analyzed a decade of data on clinical trials and venture capital investments to understand the likely trajectory of genetically focused... View Details
Keywords: Gene Therapy; Gene Editing; Impact; Health Care and Treatment; Technological Innovation; Health Testing and Trials; Venture Capital; Change
Pian, Julia, Amitabh Chandra, and Ariel Dora Stern. "The Past, Present, and (Near) Future of Gene Therapy and Gene Editing." NEJM Catalyst Innovations in Care Delivery 1, no. 5 (September–October 2020).
- 19 Feb 2015
- Video
Russ Wilcox, co-founder and CEO, Transatomic Power
William R. Kerr
William Kerr is the D’Arbeloff Professor of Business Administration at Harvard Business School. Bill is Senior Associate Dean for Faculty Development and Research, co-director of Harvard’s Managing the Future of Work initiative, and faculty chair of the... View Details
- November 2017 (Revised September 2020)
- Supplement
Miami's Tech Future (C): Reaching Another Miami
The effects of Miami’s startup scene have not reached many “left-behind” lower-income Black communities, which are disproportionately affected by problems such as segregation and racial discrimination, lack of transportation access, crime, education quality, government... View Details
Keywords: Technology; Change; Transformation; Progress; Scaling; Startup; Community Engagement; Community Impact; Community Relations; Future; Income Inequality; Business; Change Management; Business Startups; Information Technology; Diversity; Race; Equality and Inequality; Social Issues; Business and Community Relations; Miami; Florida
Kanter, Rosabeth Moss. "Miami's Tech Future (C): Reaching Another Miami." Harvard Business School Supplement 318-035, November 2017. (Revised September 2020.)
- 16 Apr 2001
- Research & Ideas
Angels Face the Innovator’s Dilemma
The venture capital industry is ripe for disruption: just like other leading mainstream companies have been for years, according to HBS professor Clayton M. Christensen. As a keynote speaker at the conference and author of the managerial... View Details
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- 2014
- Working Paper
Financing Risk and Innovation
By: Ramana Nanda and Matthew Rhodes-Kropf
We provide a model of investment into new ventures that demonstrates why some places, times, and industries should be associated with a greater degree of experimentation by investors. Investors respond to financing risk―a forecast of limited future funding―by modifying... View Details
Keywords: Business Startups; Venture Capital; Financial Markets; Financing and Loans; Investment; Price Bubble; Innovation and Invention; Technological Innovation; Risk and Uncertainty
Nanda, Ramana, and Matthew Rhodes-Kropf. "Financing Risk and Innovation." Harvard Business School Working Paper, No. 11-013, August 2010. (Revised March 2014.)
- 21 Feb 2018
- News
Investing in Tech That’s Worth the Wait
- June 2007 (Revised June 2011)
- Case
TA Energy (Turkey): A Bundle of International Partnerships
By: William R. Kerr, Daniel J. Isenberg and Ant Bozkaya
Stimulates discussion of entrepreneurship in emerging economies, especially for entrepreneurs returning to their home countries to start businesses with global technologies and partners. Focuses on the partnership tensions between global firms and local... View Details
Keywords: Family Business; Developing Countries and Economies; Entrepreneurship; Venture Capital; Globalized Firms and Management; Partners and Partnerships; Conflict and Resolution; Turkey
Kerr, William R., Daniel J. Isenberg, and Ant Bozkaya. "TA Energy (Turkey): A Bundle of International Partnerships." Harvard Business School Case 807-175, June 2007. (Revised June 2011.) (This case replaces "Bundling the Contracts: TA-Energy", Harvard Business School Case 807-075, by Kerr and Bozkaya.)
Case: Aptiv PLC Board of Directors (A)
Aptiv's board must decide whether a joint venture with an auto maker is the right next step in the company's efforts to develop and commercialize a production-ready autonomous driving system. While many commentators believed that Aptiv's self-driving technologies... View Details
- June 2017 (Revised October 2017)
- Case
Uber in 2017: One Bumpy Ride
By: Suraj Srinivasan, Jay W. Lorsch and Quinn Pitcher
Uber Technologies Inc., the popular ride-hailing company, entered 2017 having doubled its bookings in 2016 and achieving a valuation of nearly $70 billion, making it the largest venture capital-backed company in the world. Co-founder and CEO Travis Kalanick embodied... View Details
Keywords: Governance; Information Technology; Transportation; Venture Capital; Organizational Culture; Technology Industry; Technology Industry; United States
Srinivasan, Suraj, Jay W. Lorsch, and Quinn Pitcher. "Uber in 2017: One Bumpy Ride." Harvard Business School Case 117-070, June 2017. (Revised October 2017.)